This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

Tren/Test/Mast Short 150

Trenbolone acetate, testosterone propionate and drostanolone propionate in one oil: three short esters aimed at a dry look, with trenbolone's harsh profile.

4 min read 10 sources

Glass vial with golden oil and a black TPD label next to three connected blue 3D steroid molecules, symbolic image for Tren/Test/Mast Short 150
No study of its own · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

On the blend itself
0 trials

also no registered trial with trenbolone or drostanolone, as of 26 Oct 20269

Systolic hypertension
51 %

Current anabolic steroid users on 24-hour monitoring, controls 17 percent4

Aortic distensibility
-21 %

The same in current and former users, compared with controls4

Trenbolone at the androgen receptor
~3 x

About three times the affinity of testosterone, data almost only from animal studies1

With a side effect
100 of 100

Cohort of anabolic steroid users in general, four with a serious event5

  • Tren/Test/Mast Short 150 is a ready-made oil solution of trenbolone acetate, testosterone propionate and drostanolone propionate. All three act on the androgen receptor, all esters are short.108
  • There is no study on the blend itself. Trenbolone has never been approved for humans, it binds about three times as strongly as testosterone and the data come almost only from animal studies.91
  • ChEMBL lists drostanolone propionate and testosterone propionate as approved drugs. For testosterone, fat-free mass and strength rise with the dose while HDL cholesterol falls.102
  • Anabolic steroid users had shifted blood lipids, higher blood pressure and a stiffer aorta, even former users.34
  • In a cohort of 100 users every one had at least one side effect and four had a serious event. Everything here is the state of research, not a recommendation.5
Profile

Updated October 2026

Class
Anabolic steroid

oil blend of three short esters

Contents
50mg each of trenbolone acetate

testosterone propionate and drostanolone propionate per ml (150mg/ml, per product listing)

Use
Intramuscular, ready-to-use oil

10 ml

Frequency
3x per week or every other day
WADA
Banned

category S1

Sizes
10 ml

1 size in the shop

Contents 14 sections
  1. At a glance
  2. What is Tren/Test/Mast Short 150?
  3. How it works
  4. Use and dosing
  5. Injection
  6. What the research shows
  7. Research status
  8. Side effects
  9. Storage
  10. PCT / after coming off
  11. Related compounds
  12. FAQ
  13. Glossary
  14. Sources

What is Tren/Test/Mast Short 150?

Tren/Test/Mast Short 150 is a ready-made oil solution of three compounds with a combined 150mg/ml. According to the product listing each ml holds 50mg each of trenbolone acetate, testosterone propionate and drostanolone propionate (Masteron). One vial holds 10 ml and needs no mixing.

The combination is also known as TMT and, in a research context, aims at strength with a dry, hard look. All three esters are short, so the blend is given often in small amounts. Trenbolone was never approved for humans. The blend is nothing for beginners.

This information is for research and educational purposes only. No medical advice.

Comparison

The three components

Equal parts per product listing, all with a short ester. Tap a card to open the component's entry.

1610

How it works

All three compounds bind the androgen receptor. Trenbolone is the strongest part, does not aromatize and also acts on the progesterone receptor. Drostanolone is a DHT derivative that does not aromatize either and is considered mildly anti-estrogenic, while testosterone provides the base for libido and wellbeing.

Propionate and acetate have half-lives of about one to three days. Levels rise quickly and fall just as quickly after stopping. That is why three doses per week are needed to keep levels from swinging too much.

Where it acts

Where the components act

Tap a point or a card. Grey = effect seen in trials.

  1. Heart and vessels

    Systolic blood pressure higher, aorta stiffer, also in former users4

    Observed in trials
  2. Liver and blood lipids

    LDL cholesterol higher, HDL cholesterol lower3

    Observed in trials
  3. Skeletal muscle

    Fat-free mass and strength rose with the testosterone dose2

    Observed in trials
  4. Prostate

    Trenbolone: less growth in organs with 5-alpha reductase than testosterone (animal data)1

    Observed in trials
  5. Mood

    Agitation in 36 percent of users during the cycle5

    Observed in trials

Targets in the ChEMBL database10

Compound CHEMBL1201048, CHEMBL1170, CHEMBL197309: two recorded mechanisms, type of action on each card.

Androgen receptor
Gene
AR
UniProt
P10275
ChEMBL
CHEMBL1871
Action
Drostanolone and testosterone: agonist, direct binding. Trenbolone binds about three times as strongly as testosterone
Progesterone receptor
Gene
PGR
UniProt
P06401
ChEMBL
CHEMBL208
Action
Trenbolone only: binds slightly more strongly than progesterone (bovine receptor in an assay)
Three blue 3D molecules dock onto bright, blue shimmering fibres, symbolic image
Three compounds at the same receptor. Symbolic image.

Use and dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts
Glass vial with golden oil and a black TPD label, a disposable syringe in front, symbolic image
Short esters: weekly amount split into several doses. Symbolic image.

Injection

Intramuscular into the glute, thigh or shoulder, with a thick needle to draw up and a thin one (23G to 25G) to inject. Disinfect the stopper and the site first and, with this many injections, rotate sites consistently. Aspirating first and injecting slowly lowers the risk of tren cough.

Short esters sting noticeably more than long ones and irritate subcutaneous fat. Subcutaneous use is therefore a poor fit for this blend. If lumps or strong stinging appear, spread the volume over several sites.

What the research shows

Trenbolone is described as a very potent anabolic with reduced androgenic and estrogenic activity; the data come almost entirely from animal studies (Yarrow, 2010). For testosterone a dose-response study shows that fat-free mass and strength rise with the dose while HDL falls in step (Bhasin, 2001). Drostanolone used to be an approved medicine, but modern studies in healthy people are missing.

Reviews and observational studies of steroid users show shifted lipids (Achar, 2010) plus lastingly higher blood pressure with a stiffer aorta (Rasmussen, 2018). In a prospective cohort every one of 100 users had at least one side effect (Smit, 2020). No study exists for the fixed three-way combination.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Systolic hypertension on 24-hour monitoring4

Share of men doing strength training, cross-sectional study

Current users versus controls4 37 and 30 men
Current anabolic steroid users 51%
Controls without anabolics 17%

Mean 24-hour systolic blood pressure was 132 versus 124 mmHg. The study looked at anabolic steroid users in general, not this blend.

Aortic distensibility on MRI4

Difference from controls in percent

Current and former users4 37 and 33 men
Current anabolic steroid users -21%
Former users -21%

Less distensibility means a stiffer aorta. The difference also showed in former users. The natriuretic peptide MR-proANP was lowered in current users.

Fat-free mass after 20 weeks2

Gain in kg in the three higher of five dose levels, study with testosterone enanthate

Trial with five dose levels2 61 young men, 20 weeks
Level 3 of 5 +3.4 kg
Level 4 of 5 +5.2 kg
Level 5 of 5 (highest) +7.9 kg

HDL cholesterol fell in step with rising testosterone levels. There is no such human study for trenbolone or drostanolone.

Bright lab bench with sample tubes and a blood pressure monitor, symbolic image
No study on the blend, data on components and users. Symbolic image.

Research status

Where the research stands

There is no study on the blend itself. The registry also has hardly anything on the components: no trial with trenbolone or drostanolone, none in phase 2 or 3 with testosterone propionate. As of 26 Oct 2026. 9

  1. Preclinical Trenbolone: receptor assays and animal models
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
The blend is not approved. Trenbolone has never been approved for humans. ChEMBL lists testosterone propionate (since 1974) and drostanolone propionate (since 1982) as approved drugs.9

So far there is no registered trial in humans. 9

Side effects

  • Prolactin: trenbolone can cause prolactin effects, with libido and erection problems. Add prolactin to the bloodwork.
  • Lipids: HDL drops sharply and LDL rises. Trenbolone and drostanolone are both considered unfavorable here.
  • Blood pressure and heart: blood pressure and resting heart rate go up, endurance suffers. Measure regularly.
  • Sleep: trouble falling asleep, restless sleep and night sweats are typical of the tren share.
  • Mood: irritability, restlessness and aggression are reported often.
  • Skin and hair: as a DHT derivative drostanolone favors hair loss if predisposed, plus acne and oily skin.
  • Hormone axis: your own testosterone production is suppressed.

The upside of short esters: after stopping, side effects fade within a few days.

Tolerability

Side effects in anabolic steroid users

Out of 100 anabolic steroid users, how many had the event. Observational study with all agents, not a study of this blend.

58 of 100 Anabolic steroid users (all agents)
Event Anabolic steroid users (all agents)
Lower libido after the cycle5 58%
Fluid retention5 56%
Agitation5 36%
Acne5 28%
Gynaecomastia5 19%

Every one of the 100 men had at least one side effect, four had a serious event (heart failure, pancreatitis, suicidal thoughts, flare of a bowel inflammation). One year after the start the observed effects were back at baseline.5

Storage

Store at room temperature, in the dark and in the original packaging, out of reach of children. Do not put it in the fridge, because cold makes the compounds crystallize out of the oil. If you see crystals, warm the vial in your hand or in warm water and swirl until the solution is clear again. Disinfect the stopper before every draw.

Four glass vials with golden oil on a white shelf, next to them a folded light blue cloth
Store at room temperature and in the dark, not in the fridge. Symbolic image.

Related

Related compounds

Same receptors: all in the TPD lexicon.

FAQ

Common questions about Tren/Test/Mast Short 150

Short answers, each backed by the sources below.

Are there studies on this blend?

No. There is no study on the fixed three-way combination and none on trenbolone or drostanolone on the registry. Trenbolone has never been approved for humans and the data come almost only from animal studies. ChEMBL lists testosterone propionate and drostanolone propionate as approved drugs. Everything here is the state of research, not a recommendation.9110

What does each component contribute?

All three act on the androgen receptor. Trenbolone binds about three times as strongly as testosterone, is not converted to estradiol and also binds the progesterone receptor. Drostanolone is a DHT derivative, testosterone is partly converted to estradiol. All esters are short, so levels rise and fall quickly.168

What happens to blood pressure and vessels?

In a study of men doing strength training, 24-hour systolic blood pressure in current anabolic steroid users was 132 versus 124 mmHg and 51 versus 17 percent had hypertension. The aorta was 21 percent less distensible in current and former users. A review of 49 studies saw higher LDL, lower HDL and in part a thickened heart wall.43

Which side effects were seen?

There are no studies on the blend. In a cohort of 100 anabolic steroid users taking different agents every one had at least one side effect: most often fluid retention (56 percent) and agitation (36 percent) during the cycle and lower libido afterwards (58 percent). Four men had a serious event.5

Does the effect depend on the amount?

For the testosterone part, yes. In a trial with five dose levels fat-free mass rose by 3.4, 5.2 and 7.9 kg in the three higher levels while HDL cholesterol fell in step. There is no human dose study for trenbolone or drostanolone.2

Why frequent doses?

All three esters are short. For testosterone propionate a study showed that the level stayed above the physiological level for 48 hours after one injection. After that it falls quickly, which is why the entry splits the weekly amount into several doses. After stopping, effects fade correspondingly fast.7

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Androgen receptor
Protein inside the cell that all three compounds bind to. Genes are then read, for example for muscle building.
Aromatization
Conversion into estradiol by the enzyme aromatase. Testosterone is partly converted, trenbolone and drostanolone are not.
Blend
Ready-made mix of several compounds in one vial. The ratio is fixed, nothing can be adjusted on its own.
DHT
Dihydrotestosterone, a stronger androgen made from testosterone. Drostanolone is derived from it.
Ester
An attached acid chain. The shorter it is, the faster the compound is released from the oil depot.
HDL and LDL
Two cholesterol carriers in the blood. HDL is considered favourable, LDL unfavourable. Anabolics lower HDL and often raise LDL.
Hormone axis (HPTA)
Hypothalamus, pituitary and testes together control the body's own testosterone production. Anabolics from outside suppress this axis.
Progesterone receptor
Receptor for the corpus luteum hormone progesterone. Trenbolone binds it as well.
Prolactin
Pituitary hormone, among other things for milk production. Raised levels can impair libido and erection.
Stiff aorta
The main artery stretches with every heartbeat. If it is stiffer, the strain on heart and vessels rises.
WADA S1
Category of anabolic agents on the prohibited list of the World Anti-Doping Agency, banned in and out of competition.

Practice

PCT / after coming off

Anabolic substances suppress the body's own testosterone production in the research context. Anyone who comes off a cycle (rather than running it continuously) typically uses a post-cycle therapy (PCT) to restart the natural axis (HPTA).

The standard scheme in the research/literature context combines a SERM (tamoxifen and/or clomifene, alternatively enclomiphene) over roughly four weeks, optionally preceded by HCG to re-sensitise the testes before the SERM block. An aromatase inhibitor (anastrozole/exemestane) belongs more to on-cycle estrogen control than to the PCT itself.

Tip: order the PCT items together with the cycle so they are already on hand when you come off.

This information serves research and educational purposes only. Not medical advice.

Evidence

Sources

Show all 10 sourcesHide sources 8 Studies1 Trial registry1 Database checked 26 Oct 2026

Studies

  1. Trenbolone: tissue selectivity and potential applications, review

    Yarrow et al., Steroids, 2010

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Dose response in young men, five levels over 20 weeks

    Bhasin et al., American Journal of Physiology: Endocrinology and Metabolism, 2001

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. Anabolic steroids, lipids, blood pressure, heart wall and rhythm, review

    Achar et al., American Journal of Cardiology, 2010

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. Blood pressure and aortic stiffness in current and former users

    Rasmussen et al., Journal of Hypertension, 2018

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. HAARLEM: side effects in 100 anabolic steroid users over one year

    Smit et al., Scandinavian Journal of Medicine and Science in Sports, 2020

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. Binding of trenbolone to androgen and progesterone receptors in assays

    Bauer et al., APMIS, 2000

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  7. Testosterone propionate: pharmacokinetics after one injection

    Fujioka et al., Journal of Clinical Endocrinology and Metabolism, 1986

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  8. Pharmacology of anabolic steroids, review

    Kicman, British Journal of Pharmacology, 2008

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Search for trenbolone on ClinicalTrials.gov

    ClinicalTrials.gov, U.S. National Library of Medicine (auch Drostanolon und Testosteron Propionat geprüft)

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. Drostanolone propionate in ChEMBL

    ChEMBL, EMBL-EBI (CHEMBL1201048; Testosteron Propionat CHEMBL1170, Trenbolon CHEMBL197309)

    Checked 26 Oct 2026 via ChEMBL

In the shop

Tren/Test/Mast Short 150 in the catalog

Sizes, prices and shipping times are on the product page.

To the product